In Vivo Confocal Endomicroscopy of the Brain
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of the study is to test the feasibility of obtaining interpretable in vivo endomicroscopy images which can be compared with traditional histopathology. Hypothesis: That a rigid confocal endomicroscope can be used during neurosurgery to provide in vivo histology that enables differentiation of tumour tissue from normal adjacent brain tissue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Mar 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 29, 2009
CompletedFirst Posted
Study publicly available on registry
July 30, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedNovember 10, 2009
November 1, 2009
1.7 years
July 29, 2009
November 9, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To test of the ability of the surgeon to obtain interpretable images during surgery.
During surgery
Secondary Outcomes (2)
To correlate the in vivo endomicroscopy images with traditional histopathology.
one week
To evaluate the usability of the device in the OR environment.
During surgery
Study Arms (1)
All patients
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- All patients with neurosurgical pathology requiring surgery in which tumor resection might be evaluated by using biopsy.
You may not qualify if:
- Pregnant women
- Inability to give informed consent
- History of allergy to fluorescein
- Patients on beta-blockers or ACE inhibitors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Barrow Neurological Institute, St. Joseph's Hospital and Medical Center
Phoenix, Arizona, 85013, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Nakaji, MD
Barrow Neurological Institute, St. Joseph's Hospital and Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
July 29, 2009
First Posted
July 30, 2009
Study Start
March 1, 2008
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
November 10, 2009
Record last verified: 2009-11